Cost-effectiveness of pneumococcal conjugate vaccine: An update after 7 years of use in the United States-Reference-Cited by-同舟云学术

Cost-effectiveness of pneumococcal conjugate vaccine: An update after 7 years of use in the United States

Published:2009-11 Issue:47 Volume:27 Page:6483-6494
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Ray G. Thomas,Pelton Stephen I.,Klugman Keith P.,Strutton David R.,Moore Matthew R.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference54 articles.

1. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis;American Academy of Pediatrics Committee on Infectious Diseases;Pediatrics,2000

2. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP);Centers for Disease Control Prevention;MMWR Morb Mortal Wkly Rep,2000

3. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group;Black;Pediatr Infect Dis J,2000

4. Efficacy of a pneumococcal conjugate vaccine against acute otitis media;Eskola;N Engl J Med,2001

5. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia;Black;Pediatr Infect Dis J,2002

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health-economic burden attributable to novel serotypes in candidate 24- and 31-valent pneumococcal conjugate vaccines;Vaccine;2024-12

2. Health-economic burden attributable to novel serotypes in candidate 24- and 31-valent pneumococcal conjugate vaccines;2024-04-12

3. Burden of invasive pneumococcal disease, non-invasive all-cause pneumonia, and acute otitis media in hospitalized US children: a retrospective multi-center study from 2015-2020;2024-04-09

4. Outpatient Visits and Antibiotic Use Due to Higher-Valency Pneumococcal Vaccine Serotypes;The Journal of Infectious Diseases;2024-03-18

5. Pediatric outpatient visits and antibiotic use attributable to higher valency pneumococcal conjugate vaccine serotypes;2023-08-25